Table 4.

ANCOVA models for change in ghrelin over 12 weeks

Coefficient	Ratio of geometric mean [95%CI]	P‐value
Change of ghrelin
Model 1: … by baseline ghrelin
(Intercept)	4.31 [2.07–8.96]	<0.001
Ghrelin (baseline)	0.87 [0.81–0.94]	<0.001
Model 2: … by baseline ghrelin adjusted for treatment group
(Intercept)	4.23 [2.10–8.54]	<0.001
Ghrelin (baseline)	0.86 [0.81–0.93]	<0.001
Exercise training	1.09 [1.02–1.17]	0.013
Model 3: … by baseline ghrelin adjusted for treatment group and adiponectin (high)
(Intercept)	4.18 [2.02–8.62]	<0.001
Ghrelin (baseline)	0.87 [0.80–0.93]	<0.001
Exercise training	1.09 [1.02–1.17]	0.014
Adiponectin (high)	1.01 [0.94–1.07]	0.86
Model 4: … by baseline ghrelin adjusted for treatment group, interaction [exercise training: adiponectin (high)]
(Intercept)	4.37 [2.18–8.74]	<0.001
Ghrelin (baseline)	0.87 [0.81–0.93]	<0.001
Exercise training	1.01 [0.92–1.11]	0.79
Adiponectin (high)	0.90 [0.81–1.01]	0.06
Exercise training: adiponectin (high)	1.15 [1.01–1.32]	0.035

ANCOVA, analysis of covariance.

Tabulated is per model the ratio of geometric means and the P‐value of the ANCOVA test.